Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC

Condition:   Non-squamous Non-small Cell Lung Cancer Interventions:   Drug: endostar/PD-1 inhibitor;   Drug: endostar Sponsor:   Dong Wang Recruiting

Source: ClinicalTrials.gov - August 21, 2019 Category: Research Source Type: clinical trials